These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 26953217)

  • 1. Feasibility, Utility, and Safety of Midodrine During Recovery Phase From Septic Shock.
    Whitson MR; Mo E; Nabi T; Healy L; Koenig S; Narasimhan M; Mayo PH
    Chest; 2016 Jun; 149(6):1380-3. PubMed ID: 26953217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Midodrine as adjunctive support for treatment of refractory hypotension in the intensive care unit: a multicenter, randomized, placebo controlled trial (the MIDAS trial).
    Anstey MH; Wibrow B; Thevathasan T; Roberts B; Chhangani K; Ng PY; Levine A; DiBiasio A; Sarge T; Eikermann M
    BMC Anesthesiol; 2017 Mar; 17(1):47. PubMed ID: 28327122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Midodrine for the weaning of vasopressor infusions.
    Poveromo LB; Michalets EL; Sutherland SE
    J Clin Pharm Ther; 2016 Jun; 41(3):260-5. PubMed ID: 26945564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LIBERATE: a study protocol for midodrine for the early liberation from vasopressor support in the intensive care unit (LIBERATE): protocol for a randomized controlled trial.
    Opgenorth D; Baig N; Fiest K; Karvellas C; Kutsogiannis J; Lau V; Macintyre E; Senaratne J; Slemko J; Sligl W; Wang X; Bagshaw SM; Rewa OG
    Trials; 2022 Mar; 23(1):194. PubMed ID: 35246227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral midodrine treatment accelerates the liberation of intensive care unit patients from intravenous vasopressor infusions.
    Levine AR; Meyer MJ; Bittner EA; Berg S; Kalman R; Stanislaus AB; Ryan C; Ball SA; Eikermann M
    J Crit Care; 2013 Oct; 28(5):756-62. PubMed ID: 23845791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Use of Midodrine as an Adjunctive Therapy to Liberate Patients from Intravenous Vasopressors: A Systematic Review and Meta-analysis of Randomized Controlled Studies.
    Hamed M; Elseidy SA; Elkheshen A; Maher J; Elmoghrabi A; Zaghloul A; Panakos A; Panaich S; Saad M; Elbadawi A
    Cardiol Ther; 2023 Mar; 12(1):185-195. PubMed ID: 36670331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trends in Use of Midodrine in the ICU: A Single-Center Retrospective Case Series.
    Rizvi MS; Trivedi V; Nasim F; Lin E; Kashyap R; Andrijasevic N; Gajic O
    Crit Care Med; 2018 Jul; 46(7):e628-e633. PubMed ID: 29613861
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Putting midodrine on the MAP: An approach to liberation from intravenous vasopressors in vasodilatory shock.
    Smith SE; Peters NA; Floris LM; Patterson JM; Hawkins WA
    Am J Health Syst Pharm; 2022 Jun; 79(13):1047-1055. PubMed ID: 35235946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Midodrine improves clinical and economic outcomes in patients with septic shock: a randomized controlled clinical trial.
    Adly DHE; Bazan NS; El Borolossy RM; Anan IF; Fakher MA; El Wakeel LM
    Ir J Med Sci; 2022 Dec; 191(6):2785-2795. PubMed ID: 34981420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of Oral Vasopressors Used for Liberation from Intravenous Vasopressors in Intensive Care Unit Patients Recovering from Spinal Shock: A Randomized Controlled Trial.
    Ahmed Ali AT; Abd El-Aziz MA; Mohamed Abdelhafez A; Ahmed Thabet AM
    Crit Care Res Pract; 2022; 2022():6448504. PubMed ID: 35087688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical utility of midodrine and methylene blue as catecholamine-sparing agents in intensive care unit patients with shock.
    Tchen S; Sullivan JB
    J Crit Care; 2020 Jun; 57():148-156. PubMed ID: 32145658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral midodrine does not expedite liberation from protracted vasopressor infusions: A case-control study.
    Wood AJ; Rauniyar R; Jacques A; Palmer RN; Wibrow B; Anstey MH
    Anaesth Intensive Care; 2023 Jan; 51(1):20-28. PubMed ID: 36168754
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of midodrine on the prognosis of patients with septic shock: a systematic review and meta-analysis.
    He QF; Xing XK; Wang TQ; Jiang ZX; Zhang G
    Eur Rev Med Pharmacol Sci; 2023 May; 27(9):4211-4220. PubMed ID: 37203847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Impact of Midodrine Tapering Versus Nontapering Regimens on the Clinical Outcomes of Critically Ill Patients: A Retrospective Cohort Study.
    Gramish J; Hattan A; Aljuhani O; Parameaswari PJ; Alshehri S; Korayem GB; Alkofide H; Alalawi M; Vishwakarma R; Alsowaida YS; Alqahtani R; Binorayir L; Abutaleb M; Alotaibi A; Aljohani M; Aljohani S; Samreen S; Jawhari S; Alanazi R; Al Sulaiman KA
    Ann Pharmacother; 2024 Mar; 58(3):223-233. PubMed ID: 37248667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hemodynamic Instability Secondary to Vasopressin Withdrawal in Septic Shock.
    Bissell BD; Magee C; Moran P; Bastin MLT; Flannery AH
    J Intensive Care Med; 2019 Sep; 34(9):761-765. PubMed ID: 28750598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of Chronic Antihypertensives on Vasopressor Dosing in Septic Shock.
    DeMott JM; Patel G; Lat I
    Ann Pharmacother; 2018 Jan; 52(1):40-47. PubMed ID: 28799416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluating Vasopressor Discontinuation Strategies in Patients With Septic Shock on Concomitant Norepinephrine and Vasopressin Infusions.
    Musallam N; Altshuler D; Merchan C; Zakhary B; Aberle C; Papadopoulos J
    Ann Pharmacother; 2018 Aug; 52(8):733-739. PubMed ID: 29560736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of midodrine versus placebo on time to vasopressor discontinuation in patients with persistent hypotension in the intensive care unit (MIDAS): an international randomised clinical trial.
    Santer P; Anstey MH; Patrocínio MD; Wibrow B; Teja B; Shay D; Shaefi S; Parsons CS; Houle TT; Eikermann M;
    Intensive Care Med; 2020 Oct; 46(10):1884-1893. PubMed ID: 32885276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of corticosteroids on arginine vasopressin-containing vasopressor therapy for septic shock: a case control study.
    Bauer SR; Lam SW; Cha SS; Oyen LJ
    J Crit Care; 2008 Dec; 23(4):500-6. PubMed ID: 19056013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of Hyperoncotic Albumin on Duration of Vasopressor Support in Septic Shock: A Propensity Score-Matched Analysis.
    Flannery AH; Owen GD; Coz A; Thompson Bastin ML; Patel K
    Ann Pharmacother; 2021 May; 55(5):584-591. PubMed ID: 33016080
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.